Johnson and Johnson Newswire

Johnson and Johnson Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson.

Results 1 - 20 of 3,239 in Johnson and Johnson

  1. Researchers warn G7 leaders on disease preparednessRead the original story w/Photo

    2 hrs ago | PhysOrg Weblog

    In an article in the official publication for the G7 meeting at Schloss Elmau, Germany, this weekend, Professor Peter Horby, who leads the Epidemic Research Group Oxford , and Professor Adrian Hill, director of vaccine research centre the Jenner Institute, warn that it is vital to get ahead of the next outbreak. While Adrian Hill has been working on vaccines and Peter Horby on treatments for Ebola, the two say that their areas faced similar problems when the outbreak began: very few potential vaccines or treatments with little known about their safety or efficacy, and very few doses of each with no way of scaling up production quickly.


  2. How One Couple Climbed Out Of Debt And Became Millionaires In Their 30sRead the original story

    2 hrs ago |

    It was right after college graduation when starting a new life suddenly became very expensive. First, a brand new Honda Civic.


  3. Weekly Research Analysts' Ratings Changes for Johnson & JohnsonRead the original story

    5 hrs ago |

    They now have a $111.00 price target on the stock, up previously from $108.00. 5/23/2015 - Johnson & Johnson had its "sell" rating reaffirmed by analysts at Goldman Sachs.


  4. Consumer Brands, Big Investors Call for Stronger Sustainable Palm Oil StandardRead the original story w/Photo

    6 hrs ago | Triple Pundit

    In business, as is in other areas of regulated human endeavor, it pays to cheat - at least until you're caught and if the penalties are commensurate with the seriousness of the transgressions. Technically it may not qualify as cheating, but market participants that comply with the sustainable palm oil certification standard established by RSPO are playing on a field tilted in their favor as compared to those who have adopted stronger and more comprehensive standards, according to a group of prominent industry players.


  5. One Man's OpinionDID Middle East Meeting Bomb on Broadway?Read the original story

    10 hrs ago | American Reporter

    Nineteen-thirty-five was not that great a year for America. The country was still in the Depression.


  6. Sepp Blatter: pompous, bizarre, and off-key to the last breathRead the original story w/Photo

    12 hrs ago | The Age

    In news that knocked the sports world over with a feather, the 79-year-old FIFA boss Sepp Blatter resigned Tuesday at an impromptu Zurich press conference. Just three days after winning re-election for the fifth time amidst unprecedented scandal, Blatter's 17-year reign has come to an end.


  7. Pharmaceutical companies called on to explain tiny tax contributionRead the original story w/Photo

    15 hrs ago | The Age

    The five biggest suppliers of publicly subsidised medicines in Australia recorded sales of nearly $5 billion last year but paid an average of just $10 million each in company tax. They paid $53 million in tax between them - or roughly one cent in tax for every dollar earned in Australia Research by the Parliamentary Library, obtained by Fairfax Media, has disclosed the tax contribution of multinational pharmaceutical companies, including Pfizer and AstraZeneca, makers of common cholesterol drugs Lipitor and Crestor, respectively.


  8. Photo Flash: Finding Neverland's Matthew Morrison Honored at 2015 Glsen Respect AwardsRead the original story w/Photo

    16 hrs ago |

    Last night at GLSEN's Respect Awards in New York City, Glee's Matthew Morrison was honored with the Inspiration Award for portraying a shining example of the vital role a supportive educator can have in creating an affirming, positive and supportive school culture for LGBT students. Other honorees of the night included John Stryker, Desiree Raught and Johnson & Johnson.


  9. Why Health Care Stocks Will Continue to Lead Market HigherRead the original story w/Photo

    18 hrs ago |

    NEW YORK -- Health care stocks have traditionally been viewed as defensive, but over the past 5 years the sector has been the best performer the S&P 500. Mario Minot, partner at Minotti Group Wealth Advisors, says the run in healthcare names is far from over.


  10. Emami buys Kesh KingRead the original story w/Photo

    19 hrs ago | The Telegraph

    Calcutta, June 2: Emami Ltd has entered into an agreement with Sanjeev Juneja to acquire the hair and scalp care business under the Kesh King and allied brands for Rs 1,651 crore. The shares of Emami were down 5.8 per cent to Rs 1,066.15 on the Bombay Stock Exchange today.


  11. Why Healthcare Stocks Will Continue to Lead Market HigherRead the original story w/Photo

    19 hrs ago |

    Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 9+ You may proceed to the site by clicking here , however some pages might not work correctly.


  12. Sepp Blatter's Shocking EndRead the original story w/Photo

    20 hrs ago | The Nation

    In news that knocked the sports world over with a feather, FIFA Boss, the 79-year-old Sepp Blatter resigned Tuesday at an impromptu Zurich press conference. Just three days after winning reelection for the fifth time amidst unprecedented scandal, the 17-year reign of Blatter now has an ending.


  13. McCormick & Company Appoints Two New Board of Directors MembersRead the original story w/Photo

    21 hrs ago | Grocery Headquarters

    McCormick & Company, Incorporated, a global leader in flavor has appointed two new board of directors members. Michael Conway, president, global channel development for Starbucks Coffee Company and Maritza G. Montiel, former Deputy CEO and vice chairman of Deloitte LLP have been appointed to the board of directors of McCormick.


  14. Could Johnson & Johnson Divest More Assets?Read the original story w/Photo

    22 hrs ago | Investopedia

    Operating in both high-margin developed countries as well as emerging markets, which offer plenty of long-term potential but currently may not offer substantial profits, gives Johnson & Johnson and investors ample avenues for growth. J&J's product diversity also helps.


  15. Johnson & Johnson: Scary News Offers Opportunities To Increase Dividend Income For RetirementRead the original story w/Photo

    22 hrs ago | Seeking Alpha

    To the delight of DGI investors, it offers opportunities to add more share or open a position at higher dividend yields. Johnson & Johnson has been in the news lately and the news has sent the share price lower, actually hitting $99.75 last Friday.


  16. Johnson & Johnson Is Healthy But OvervaluedRead the original story w/Photo

    22 hrs ago | Seeking Alpha

    The market is implying 5.27% earnings growth over the next 7-10 years, but in recent years, the company's earnings growth has not been that strong. A lot of investors and analysts considering Johnson & Johnson are focused primarily on qualitative speculation about the company's prospects.


  17. FBI Investigating Whether J&J Ignored Safety ConcernsRead the original story

    Yesterday | Outpatient Surgery Magazine

    The FBI wants to know what Johnson & Johnson knew about the potential dangers of power morcellators, and when the largest manufacturer of the device knew it, according to a report in the Wall Street Journal . Morcellators have been a flashpoint for controversy since 2013, when Amy Reed, MD, PhD, an anesthesiologist at Beth Israel Deaconess Medical Center in Boston, Mass., went public with the revelation that morcellation had upstaged a leiomyosarcoma to stage IV cancer during her hysterectomy.


  18. W&M takes on IPAB, medical device tax repeal - White House looks at ...Read the original story

    Yesterday | Politico

    TODAY: W&M SETS UP THE HOUSE FOR McCARTHY'S HEALTH CARE WEEK - Everyone will be watching the Supreme Court later this month in anticipation of a ruling in the King v. Burwell case.


  19. Shrink, Shrank, Shrunk: A Picture Of The U.S. EconomyRead the original story w/Photo

    Yesterday | Seeking Alpha

    The Commerce Department kicked off the weekend with a bit of bad news: it turns out that instead of growing by 0.2 percent, the US economy actually shrank by 0.7 percent in the first three months of the year. A bad winter, the strengthening dollar, spending-averse consumers and a shutdown at West Coast ports contributed to the contraction.


  20. Johnson & Johnson Roundup: Latest Updates Suggest Growing Push In PipelineRead the original story w/Photo

    Yesterday |

    Great Speculations' contributor page is devoted to investing ideas that will help make you wiser and richer. Most articles will contain actionable advice.